Search

Lawrence M Kauvar

from San Francisco, CA
Age ~73

Lawrence Kauvar Phones & Addresses

  • 1438 Green St UNIT 7A, San Francisco, CA 94109 (415) 567-6815
  • 1438 Green St, San Francisco, CA 94109
  • Pasadena, CA
  • 1438 Green St UNIT 7A, San Francisco, CA 94109

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lawrence M. Kauvar
President
ARUNDEL HOMEOWNERS ASSOCIATION, INC
Membership Organization
1700 Jackson St, San Francisco, CA 94109
1906 Un St, San Francisco, CA 94123

Publications

Us Patents

High Throughput Microscopy

View page
US Patent:
6444992, Sep 3, 2002
Filed:
Sep 13, 1999
Appl. No.:
09/394842
Inventors:
Lawrence M. Kauvar - San Francisco CA
John Sedat - San Francisco CA
Assignee:
Trellis Bioscience, Inc. - Mountain View CA
International Classification:
G01N 2164
US Classification:
2504611, 2504581
Abstract:
An apparatus for high resolution, high throughput, three-dimensional fluorescence microscopy with a rotatable circular disc for mounting samples to be viewed and multiple CCDs and beam splitters as detectors for the fluorescence emission.

Method To Assess Library X Library Interactions

View page
US Patent:
6492125, Dec 10, 2002
Filed:
Jun 14, 1999
Appl. No.:
09/332613
Inventors:
Lawrence M. Kauvar - San Francisco CA
John Sedat - San Francisco CA
Assignee:
Trellis Bioscience, Inc. - Mountain View CA
International Classification:
G01N 3353
US Classification:
435 71, 435 792, 435 793, 435DIG 1, 435DIG 2, 435DIG 14, 435DIG 40, 435DIG 41, 436518
Abstract:
Particulate labels that can be individually identified comprise particulate supports to which are bound at least two distinguishable signal-generating moieties, such as fluorophores emitting at different wavelengths, which signals are detectable and measurable in situ. By varying the ratio and/or amounts of the signal-generating moieties, a multiplicity of different and distinguishable labels is obtained. Each different label can then be coupled to a different reagent and the individual interactions of each reagent with a target observed in parallel.

Multihued Labels

View page
US Patent:
6642062, Nov 4, 2003
Filed:
Sep 3, 1998
Appl. No.:
09/146984
Inventors:
Lawrence M. Kauvar - San Francisco CA
John Sedat - San Francisco CA
Assignee:
Trellis Bioinformatics, Inc. - San Francisco CA
International Classification:
G01N 33543
US Classification:
436518, 435 6, 435DIG 34, 435DIG 40, 435DIG 41, 536 231, 530333
Abstract:
Particulate labels that can be individually identified comprise particulate supports to which are bound at least two distinguishable signal generating moieties, such as fluorophores emitting at different wavelengths, which signals are detectable and measurable in situ. By varying the ratio and/or amounts of the signal generating moieties, a multiplicity of different and distinguishable labels is obtained. Each different label can then be coupled to a different reagent and the individual interactions of each reagent with a target observed in parallel.

Protein Localization Assays For Toxicity And Antidotes Thereto

View page
US Patent:
6673554, Jan 6, 2004
Filed:
Jun 14, 1999
Appl. No.:
09/332611
Inventors:
Lawrence M. Kauvar - San Francisco CA
Assignee:
Trellie Bioinformatics, Inc. - San Francisco CA
International Classification:
G01N 3353
US Classification:
435 71, 435 6, 435 72, 435 78, 436 35, 436 63
Abstract:
Intracellular translocation of proteins, particularly protein kinase C (PKC) isoenzymes, provides a surrogate test system for determining toxicity of candidate compounds. The profile of translocation with respect to at least one and preferably two or more signal transduction proteins can be correlated with that of known toxins. In addition, databases of such profiles with respect to toxins of various types provide a useful set of standards for evaluating toxicity of candidate compounds. Moreover, to the extent that a toxins profile mimics that found in a diseased state, the toxin can be used to construct screens for compounds alleviating the disease.

Cell-Signaling Assays

View page
US Patent:
6806053, Oct 19, 2004
Filed:
Jan 23, 2001
Appl. No.:
09/768661
Inventors:
J. Richard Sportsman - Palo Alto CA
Lawrence M. Kauvar - San Francisco CA
Assignee:
LJL BioSystems, Inc. - Sunnyvale CA
International Classification:
G01N 33533
US Classification:
435 71, 435 7021, 436518
Abstract:
Assays for detecting the presence and activity of cell-signaling components. These assays include luminescence polarization assays for detecting cell-signaling nucleotides and modulators of receptors and enzymes related to the generation and activity of such nucleotides.

Nonpeptide Insulin Receptor Agonists

View page
US Patent:
RE38915, Dec 6, 2005
Filed:
Dec 21, 2000
Appl. No.:
09/748665
Inventors:
Richard Sportsman - Palo Alto CA, US
Hugo O. Villar - Newark CA, US
Lawrence M. Kauvar - San Francisco CA, US
Wayne R. Spevak - Albany CA, US
Assignee:
Telik, Inc. - Palo Alto CA
International Classification:
A61K031/05
A61K031/10
A61K031/17
A61K031/655
US Classification:
514 4, 514150, 514477, 514483, 514562, 514563, 514596, 514597, 514598, 514617, 514618, 514619, 514616, 514708, 514762, 514866
Abstract:
Modulation of the activity of the insulin receptor, enhancement of glucose uptake by cells, and other effects significant in the control and management of diabetes are accomplished using compounds of the formula wherein.

Therapeutic Compositions Containing Glutathione Analogs

View page
US Patent:
7029695, Apr 18, 2006
Filed:
Jul 10, 2001
Appl. No.:
09/903442
Inventors:
Thomas Redelmeier - Vancouver, CA
Lawrence M. Kauvar - San Francisco CA, US
Robert T. Lum - Palo Alto CA, US
Matthew H. Lyttle - Point Reyes Station CA, US
Robert W. Macsata - Pleasanton CA, US
Steven R. Schow - Redwood Shores CA, US
Hugo O. Villar - La Jolla CA, US
Michael R. Kozlowski - Poway CA, US
Assignee:
Telik, Inc. - Palo Alto CA
International Classification:
A61K 9/127
A61K 38/06
C07K 5/08
US Classification:
424450, 514 18, 530331
Abstract:
Pharmaceutical compositions and methods of using them. Lipid formulations of a glutathione analog and methods of manufacturing them. Their use to stimulate hematopoiesis, protect hematopoietic cells from damage caused by radiation or chemotherapy, or potentiate the stimulatory action of one or a combination of cytokines on colony formation by hematopoietic progenitor cells, protect a subject from a destructive effect of a chemotherapeutic agent or irradiation, or to potentiate the effect of a chemotherapeutic agent.

Real Time Detection Of Intermolecular Interaction

View page
US Patent:
7238490, Jul 3, 2007
Filed:
Jul 21, 2005
Appl. No.:
11/187336
Inventors:
Lawrence M. Kauvar - San Francisco CA, US
Assignee:
Trellis Bioscience, Inc. - South San Francisco CA
International Classification:
G01N 33/53
US Classification:
435 71, 435 792, 436501, 436518
Abstract:
Intermolecular binding can be detected by formation of a “paratope” which results in an immediate generation of a signal. The substances to be tested for interaction are bound to demitopes, wherein said demitopes are components of a paratope which binds a reporter which provides said signal when bound. Known interactions measured in this way can also be employed to screen for compounds which interfere with the interactions. In addition to testing for individual interactions, the interaction of a compound with a library or library×library interactions can also be determined and the effect of potentially interfering substances evaluated.
Lawrence M Kauvar from San Francisco, CA, age ~73 Get Report